+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07185919

Long-term Safety and Effectiveness Registry of Odevixibat Bylvay in People with Progressive Familial Intrahepatic Cholestasis PFIC in South Korea

Led by Ipsen · Updated on 2026-10-23

10

Participants Needed

5

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting information from people with Progressive Familial Intrahepatic Cholestasis PFIC, a rare liver condition that causes itching and yellowing of the skin. The study focuses on individuals using odevixibat, a medicine approved in several regions including South Korea, the EU, and the US, to help manage PFIC symptoms. This observational study aims to understand the long-term safety and effectiveness of odevixibat in daily use. Participants in this study are those who have been prescribed odevixibat and may be currently taking it or starting treatment. The study observes participants over approximately 7 years, tracking their health while they use odevixibat in regular care settings. There are no additional experimental treatments instead, the study records real-world outcomes as participants continue their prescribed medication. During the study, researchers gather data on adverse events and monitor important health outcomes such as survival without surgery, liver transplant, or other complications. The study collects this information from the time participants consent until the end of data collection, which lasts about 7 years. Participants will have periodic assessments as part of their routine care, and the study aims to provide a detailed view of odevixibats long-term use in people with PFIC.

CONDITIONS

Brief Title

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

Research Team

I

Ipsen Clinical Study Enquiries

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here